title: Report of the Working Party Group on Determining the Radionuclide of Choice.
abstract: There are a variety of radiopharmaceuticals that can be used to perform captopril renography effectively. We examined a number of technetium and iodine compounds and the circumstances under which each radiopharmaceutical compound is the compound of choice. Considerations of cost, ease of use, reliability, dosage, and the effects of different protocols were all examined.
authors.affiliation: Albert Einstein College of Medicine, Bronx, NY 10461.
authors.forename: M D
authors.initials: MD
authors.lastname: Blaufox
authors.forename: E V
authors.initials: EV
authors.lastname: Dubovsky
authors.forename: A J
authors.initials: AJ
authors.lastname: Hilson
authors.forename: A
authors.initials: A
authors.lastname: Taylor
authors.forename: R
authors.initials: R
authors.lastname: de Zeeuw
mesh_terms: D002216:Captopril; D006801:Humans; D006978:Hypertension, Renovascular / Q000000981:diagnostic imaging*; D007457:Iodine Radioisotopes; D007465:Iodohippuric Acid; D015609:Organotechnetium Compounds; D011866:Radioisotope Renography / Q000379:methods*
chemical_list: D007457:Iodine Radioisotopes; D015609:Organotechnetium Compounds; D007465:Iodohippuric Acid; D002216:Captopril